The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.

A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med (1997) 1.67

Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J Exp Med (1998) 1.44

A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci U S A (1996) 1.19

Studies on the thymus of non-obese diabetic (NOD) mice: effect of transgene expression. Immunology (1994) 0.84

Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A (2013) 0.79

Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells. Immunology (1997) 0.77

Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny. Proc Natl Acad Sci U S A (2017) 0.75

A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44

The flow of oxygen through the pulmonary epithelium. J Physiol (1920) 9.27

In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J Exp Med (1975) 5.53

Characterization of subpopulations of T lymphocytes. I. Separation and functional studies of peripheral T-cells binding different amounts of fluorescent anti-Thy 1.2 (theta) antibody using a fluorescence-activated cell sorter (FACS). Cell Immunol (1975) 4.13

The structure of a mutant H-2 gene suggests that the generation of polymorphism in H-2 genes may occur by gene conversion-like events. Nature (1983) 3.99

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol (1990) 3.54

Responsiveness to HY antigen Ir gene complementation and target cell specificity. Immunol Rev (1977) 3.03

Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature (1991) 2.65

T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol (2001) 2.23

Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature (1990) 2.23

Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Br J Surg (2012) 2.17

Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature (1990) 2.10

Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J Gen Virol (1980) 1.96

Hybrid cell lines with T-cell characteristics. Nature (1977) 1.96

Expression of murine H-2Kb histocompatibility antigen in cells transformed with cloned H-2 genes. Nature (1982) 1.91

Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity. Eur J Immunol (1976) 1.90

Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev Immunol (1993) 1.87

A survey of weighing performance in clinical biochemistry laboratories. Clin Chim Acta (1978) 1.85

Identification of a mouse male-specific transplantation antigen, H-Y. Nature (1995) 1.82

Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79

Regulation of the immune response by subclasses of T lymphocytes. II. The effect of adult thymectomy upon humoral and cellular responses in mice. Eur J Immunol (1975) 1.79

Regulation of the immune response by subclasses of T lymphocytes. I. Interactions between pre-killer T cells and regulatory T cells obtained from peripheral lymphoid tissues of mice. Eur J Immunol (1975) 1.72

The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen. J Exp Med (1976) 1.67

Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Genomics (2001) 1.58

Multi-modality megatherapy with [131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma. Eur J Cancer (1995) 1.58

Parasitic worms and inflammatory diseases. Parasite Immunol (2006) 1.58

Biochemical assessment of protein-calorie malnutrition. Lancet (1969) 1.55

Cytotoxic T-cell responses to H-Y: mapping of the Ir genes. J Exp Med (1978) 1.53

Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc Natl Acad Sci U S A (1992) 1.52

Impact of changing diagnostic criteria on incidence, management, and outcome of acute myocardial infarction: retrospective cohort study. BMJ (2003) 1.52

Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts. J Exp Med (1978) 1.51

Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol (2005) 1.50

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol (2000) 1.49

Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies. J Autoimmun (1988) 1.49

A glycophospholipid anchor is required for Qa-2-mediated T cell activation. Nature (1989) 1.48

The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol (1997) 1.46

Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. J Gen Virol (1980) 1.45

Booster seat use and reasons for nonuse. Pediatrics (2000) 1.41

Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol (1991) 1.41

Autoreactive T-cell lines specific for mouse thyroglobulin. Immunology (1985) 1.41

Variable transfer of Y-specific sequences in XX males. Nucleic Acids Res (1986) 1.40

Third party mediated graft rejection despite irradiation of blood products. Br J Haematol (1992) 1.39

The Prader-Willi syndrome. Arch Dis Child (1994) 1.39

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review. Health Technol Assess (2009) 1.37

In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest (1995) 1.36

MHC matching shows that at least two T-cell subsets determine resistance to HSV. Nature (1979) 1.35

An H-YDb epitope is encoded by a novel mouse Y chromosome gene. Nat Genet (1996) 1.35

Characterization of genes encoding translation initiation factor eIF-2gamma in mouse and human: sex chromosome localization, escape from X-inactivation and evolution. Hum Mol Genet (1998) 1.34

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health Technol Assess (2009) 1.33

Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol (2000) 1.32

Male sexual differentiation in mice lacking H-Y antigen. Nature (1985) 1.32

Idiotypic networks and their possible exploitation for manipulation of the immune response. Lancet (1981) 1.29

Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity (2000) 1.29

Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells. J Immunol (1983) 1.29

Tumour growth in nematode-infected animals. Lancet (1971) 1.28

Analysis of stress levels among medical students, residents, and graduate students at four Canadian schools of medicine. Acad Med (1997) 1.26

Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol (1998) 1.26

Nitrogen cycling by wood decomposing soft-rot fungi in the "King Midas tomb," Gordion, Turkey. Proc Natl Acad Sci U S A (2001) 1.25

Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immunol (1998) 1.25

Red cell volume and cardiac output in anaemic preterm infants. Arch Dis Child (1990) 1.22

H-2 complementation in anti-H-Y cytotoxic T-cell responses can occur in chimeric mice. Proc Natl Acad Sci U S A (1978) 1.21

Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis (1973) 1.20

Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J Exp Med (1991) 1.20

The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J Autoimmun (1990) 1.19

Mapping the testis determinants by an analysis of Y-specific sequences in males with apparent XX and XO karyotypes and females with XY karyotypes. Nucleic Acids Res (1987) 1.18

Autoimmunity and idiotypes. Lancet (1984) 1.17

Cross-reactive cytotoxic responses. H-2 restricted are more specific than anti-H-2 responses. J Exp Med (1978) 1.17

Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol (1999) 1.16

Duchenne muscular dystrophy due to familial Xp21 deletion detectable by DNA analysis and flow cytometry. Hum Genet (1986) 1.16

The relationship between dissociative symptoms, alexithymia, impulsivity, sexual abuse, and self-mutilation. Compr Psychiatry (1996) 1.15

Biotin labeling of red cells in the measurement of red cell volume in preterm infants. Pediatr Res (1990) 1.15

Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology (1994) 1.15

The long-term sequelae of sexual abuse: support for a complex posttraumatic stress disorder. J Trauma Stress (1996) 1.15

Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis. J Immunol (2001) 1.15

Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15

Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes (1993) 1.15

Immune-response gene control of cytotoxic T-cell responses to H-Y. Transplant Proc (1977) 1.14

Phenotypic and functional studies of human peripheral blood lymphocytes engrafted in scid mice. Immunol Rev (1991) 1.14

Stimulation of mixed lymphocyte cultures and cytotoxic responses: evidence that T cells express SD but not LD antigens, whereas B cells express both. Eur J Immunol (1976) 1.14

Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J Immunol (2001) 1.13

Immunoglobulins, transferrin, caeruloplasmin and heterophile antibodies in kwashiorkor. Trop Geogr Med (1970) 1.12

Hormonal therapies for early breast cancer: systematic review and economic evaluation. Health Technol Assess (2007) 1.12

Congenital central hypoventilation syndrome and Hirschsprung's disease. Arch Dis Child (1998) 1.11

Genotype-phenotype correlations in XX males and their bearing on current theories of sex determination. Hum Genet (1990) 1.10

Scrapie in immunologically deficient mice. Nature (1971) 1.10